Skip to main content
DongKookPharmaceuticalCo.,Ltd. logo

DongKookPharmaceuticalCo.,Ltd. — Investor Relations & Filings

Ticker · 086450 ISIN · KR7086450004 KO Manufacturing
Open in API
Filings indexed 160 across all filing types
Latest filing 2019-02-25 AGM Information
Country KR South Korea
Listing KO 086450

About DongKookPharmaceuticalCo.,Ltd.

https://www.dkpharm.co.kr/en/

DongKook Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and distribution of medical products. Established in 1968, the company focuses on improving human health and quality of life. Its product portfolio includes prescription and non-prescription drugs, with key therapeutic areas in anesthetics, contrast media, anti-cancer agents, antibiotics, and oral healthcare treatments. The company operates its own Active Pharmaceutical Ingredient (API) synthesis facilities and invests in research and development to create innovative therapeutic solutions. It provides both finished products and raw materials to domestic and international markets.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a short regulatory filing (660 characters) from Dongkook Pharmaceutical Co., Ltd. notifying the exchange of the reason for holding their Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It is a specific regulatory disclosure required by the KOSDAQ association. Since it is a regulatory announcement regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2019-02-25 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Dongkook Pharmaceutical. It outlines the date, location, and agenda items (financial statements, director appointments, and remuneration limits) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation or notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2019-02-21 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Dongkook Pharmaceutical regarding the decision to pay cash dividends. It specifies the dividend amount per share, the dividend record date, the total dividend amount, and the scheduled date for the general meeting of shareholders to approve the dividend. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2019-02-07 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed by the National Pension Service (국민연금공단) regarding their stake in Dongkook Pharmaceutical (동국제약). This is a standard regulatory filing in South Korea used to disclose changes in significant share ownership (crossing the 5% threshold). Based on the provided categories, this fits the 'Major Shareholding Notification' (MRQ) classification.
2019-01-04 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) for Dongkook Pharmaceutical. It lists the agenda items (amendment of articles of incorporation, appointment of a director) and the outcome of the votes (approved as proposed). This falls under the category of Declaration of Voting Results.
2018-12-14 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the suspension of share registration (closing of the shareholder register) for Dongkuk Pharmaceutical. It specifies a record date and a period for the suspension to determine voting rights for the upcoming Annual General Meeting. Since this is a regulatory notice regarding corporate administrative procedures and does not fit into specific categories like dividend announcements or share buybacks, it is classified as a general regulatory filing.
2018-12-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.